ArticleEClinicalMedicine2023

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

Gustavo H Dayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.